Clinical Trial Update: Semaglutide Effectiveness in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease in the Real World Practice

View source ↗

Summary

Clinical trial update examining semaglutide effectiveness in real-world patients with metabolic dysfunction-associated fatty liver disease (MAFLD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Center of target therapy | Conditions: MAFLD | Status: ACTIVE_NOT_RECRUITING